Replies to post #25469 on Cytodyn Inc (CYDY)

[Inoviorulez]

The science always plays out in the end. Another guy I will look back to find his name I think it was pearson but he was a known short seller of many stocks (not a very good one) and stated that Avexis was worthless and heading to "0" I believe the share price was around $40 to $50 per share. Well it finally got bought out by Novartis for $8.7 billion

https://www.novartis.com/news/media-releases/novartis-enters-agreement-acquire-avexis-inc-usd-87-bn-transform-care-sma-and-expand-position-gene-therapy-and-neuroscience-leader

My point being is that Adam F and all these other short sellers are paid to write bash articles. Anyways CYDY as soon as it starts executing on the BLA filing and gets approval things will start to stack up fast. I think CYDY is one of the better long-term biotechs to own.

[trding]

That is true, probably one of the few benefits to being on OTC. Very few brokers allow one to short OTC, IB does, but I don't know of many other than that. Also even if you find a broker, you would have to put up $2.50 per share to short a share at $0.60, making it very unattractive.